Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1000 of 1631 entries
View as:

Effect of Rifampin on the Pharmacokinetics of BAY73-4506

Phase: N/A Priority: Normal
NCT ID: NCT01322438 Org: User:
Start: 03/31/11 End: 06/30/11 Due: 06/30/12

To Evaluate Effectiveness of Visanne in Improving Quality of Life in Asian Women With Endometriosis

Phase: N/A Priority: Normal
NCT ID: NCT02425462 Org: User:
Start: 04/28/15 End: 12/14/18 Due: 12/14/19

Evaluation of the Stinging Potential of Sunscreen Products in Human Eyes

Phase: N/A Priority: Normal
NCT ID: NCT02869113 Org: User:
Start: 01/23/15 End: 01/24/15 Due: 01/24/16

Asian Subjects With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01584830 Org: User:
Start: 04/30/12 End: 01/31/16 Due: 01/31/17

Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02258464 Org: User:
Start: 03/02/15 End: 08/13/19 Due: 08/13/20

Naproxen Sodium ER Pharmacokinetic Study

Phase: N/A Priority: Normal
NCT ID: NCT00818415 Org: User:
Start: 11/30/08 End: 11/30/08 Due: 11/30/09

A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy

Phase: N/A Priority: Normal
NCT ID: NCT06854640 Org: User:
Start: 03/12/25 End: 05/10/26 Due: 05/10/27

Real-Life Evidence on Stroke Prevention in SPAF

Phase: N/A Priority: Normal
NCT ID: NCT02485873 Org: User:
Start: 05/31/15 End: 09/30/15 Due: 09/30/16

Rogaratinib (BAY1163877) in Chinese Patients

Phase: N/A Priority: Normal
NCT ID: NCT03788603 Org: User:
Start: 01/07/19 End: 04/14/20 Due: 04/14/21

BAY88-8223, Does Response Study in HRPC Patients

Phase: N/A Priority: Normal
NCT ID: NCT00667199 Org: User:
Start: 05/30/05 End: 10/06/09 Due: 10/06/10

Xarelto for Real Life Anticoagulation in Pulmonary Embolism (PE) in China

Phase: N/A Priority: Normal
NCT ID: NCT03410706 Org: User:
Start: 02/01/18 End: 12/24/21 Due: 12/24/22

A Local Retrospective Observational Study to Evaluate the Treatment Patterns of mCRPC Patients in Belgium Treated With Radium-223

Phase: N/A Priority: Normal
NCT ID: NCT03563014 Org: User:
Start: 07/31/18 End: 01/31/19 Due: 01/31/20

EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02092818 Org: User:
Start: 05/31/14 End: 06/29/18 Due: 06/29/19

A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Reduced Ejection Fraction

Phase: N/A Priority: Normal
NCT ID: NCT02992288 Org: User:
Start: 02/22/17 End: 05/16/18 Due: 05/16/19

Cross -Over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel

Phase: N/A Priority: Normal
NCT ID: NCT01096498 Org: User:
Start: 02/28/09 End: 03/31/09 Due: 03/31/10

First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

Phase: N/A Priority: Normal
NCT ID: NCT06217822 Org: User:
Start: 03/07/24 End: 05/24/31 Due: 05/24/32

Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chronic Kidney Disease Alone

Phase: N/A Priority: Normal
NCT ID: NCT01807221 Org: User:
Start: 06/17/13 End: 12/09/14 Due: 12/09/15

A Study Investigating Routine Practice of Chronic Thromboembolic Pulmonary Hypertension Management in EMEA Countries

Phase: N/A Priority: Normal
NCT ID: NCT02637050 Org: User:
Start: 03/03/16 End: 09/17/20 Due: 09/17/21

Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand Eczema

Phase: N/A Priority: Normal
NCT ID: NCT00488241 Org: User:
Start: 06/30/07 End: 09/30/07 Due: 09/30/08

Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization

Phase: N/A Priority: Normal
NCT ID: NCT02260687 Org: User:
Start: 12/05/14 End: 08/22/18 Due: 08/22/19

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

Phase: N/A Priority: Normal
NCT ID: NCT01012973 Org: User:
Start: 10/31/09 End: 02/29/12 Due: 02/28/13

A Study to Learn How BAY94-8862 Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body in Adult Participants With Reduced Kidney Function and in Healthy Participants With Similar Age, Weight and Gender Distribution

Phase: N/A Priority: Normal
NCT ID: NCT04908436 Org: User:
Start: 10/27/10 End: 01/27/12 Due: 01/27/13

Inhaled Iloprost (Ventavis): Efficacy, Safety, and Pharmacokinetics (PK) Confirmation Study

Phase: N/A Priority: Normal
NCT ID: NCT01469169 Org: User:
Start: 06/19/12 End: 12/14/16 Due: 12/14/17

Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT00307801 Org: User:
Start: 02/28/06 End: 05/31/08 Due: 05/31/09

US Ovulation Inhibition Study in Obese Women

Phase: N/A Priority: Normal
NCT ID: NCT00873483 Org: User:
Start: 04/30/09 End: 03/03/10 Due: 03/03/11